Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Therapeutics
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Breast Cancer Vaccine
      • Introduction
      • Markets
      • Science
      • Collaborators
  • Diagnostics
    • Cchek™
    • Markets
    • Science
    • Collaborators
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Presentations
    • Publications
  • Contact Us

News Releases

Investors

Investors

  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • All News
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

Anixa Biosciences to Present Cchek™ Technology and Data at the Molecular Medicine Tri-Conference

March 4, 2019

Anixa Biosciences to Present Latest Prostate Cancer Data at the 2019 American Association for Cancer Research (AACR) Annual Meeting

February 28, 2019

Anixa Biosciences Announces Partnership with ResearchDx for Launch of Cchek™ Prostate Cancer Confirmation Test

February 25, 2019

Anixa Biosciences Extends Collaborative Research Agreement with The Wistar Institute and Leading Myeloid-derived Suppressor Cell Researcher Dmitry I. Gabrilovich, M.D., Ph.D.

February 21, 2019

Anixa Biosciences to Present at Moffitt Cancer Center's Business of Biotech Conference

February 13, 2019

Anixa Biosciences Conference Call Recording Available on Company Website

January 25, 2019

Anixa Biosciences CAR-T Cancer Therapy Patent Receives Notice of Allowance

January 24, 2019

Anixa Biosciences to Hold Conference Call to Discuss Outlook for 2019

January 16, 2019

Anixa Biosciences Announces Completion of Pre-Sub Meeting with FDA for its Cchek™ Cancer Diagnostic Test

December 19, 2018

Anixa Biosciences Presents Positive Data on its Liquid Biopsy for Early Detection of Breast Cancer at AACR Conference

December 3, 2018

RSS
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...14
  • Next »

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Dec 2, 2019

Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium

Read More...
Nov 26, 2019

Anixa Biosciences Announces Genesis Research to Join Cchek™ Prostate Cancer Study

Read More...
Nov 22, 2019

Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek™ Prostate Cancer Study

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.

Copyrights © 2019 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap